HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F P M O'Harte Selected Research

glycated insulin

2/2006Meal-dependent regulation of circulating glycated insulin in type 2 diabetic subjects.
9/2003Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes.
4/2003Demonstration of increased concentrations of circulating glycated insulin in human Type 2 diabetes using a novel and specific radioimmunoassay.
12/2002Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F P M O'Harte Research Topics

Disease

18Type 2 Diabetes Mellitus (MODY)
10/2016 - 09/2002
11Insulin Resistance
10/2016 - 12/2002
9Body Weight (Weight, Body)
10/2016 - 09/2002
8Obesity
12/2021 - 02/2003
2Glucose Intolerance
05/2005 - 12/2002
1Diabetes Mellitus
12/2002

Drug/Important Bio-Agent (IBA)

11Glucose (Dextrose)FDA LinkGeneric
01/2016 - 09/2002
8Peptides (Polypeptides)IBA
12/2021 - 02/2003
8Insulin (Novolin)FDA Link
12/2014 - 12/2002
6Glucagon-Like Peptide 1 (GLP 1)IBA
03/2011 - 12/2003
5Hormones (Hormone)IBA
07/2007 - 12/2003
4glycated insulinIBA
02/2006 - 12/2002
3Glucagon (Glukagon)FDA Link
10/2016 - 03/2004
3Glucagon Receptors (Glucagon Receptor)IBA
01/2016 - 12/2013
3Pro(3)- glucose-dependent insulinotropic polypeptideIBA
08/2013 - 02/2003
3IncretinsIBA
08/2004 - 02/2003
2(pGlu-Gln)-CCK-8IBA
08/2013 - 10/2012
2Cholecystokinin (Pancreozymin)IBA
08/2013 - 10/2012
2gastric inhibitory polypeptide receptorIBA
08/2013 - 07/2007
2Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
08/2013 - 07/2007
2Nateglinide (Starlix)FDA LinkGeneric
03/2011 - 09/2003
2Metformin (Glucophage)FDA LinkGeneric
06/2009 - 05/2005
2exendin (9-39)IBA
05/2005 - 02/2003
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
05/2005 - 12/2003
1apelin-13 peptideIBA
01/2018
1Blood Glucose (Blood Sugar)IBA
12/2014
1CholesterolIBA
12/2014
1monomethoxypolyethylene glycol (MPEG)IBA
08/2013
1Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
08/2013
1Triglycerides (Triacylglycerol)IBA
10/2012
1LipidsIBA
07/2007
1gastric inhibitory polypeptide (3-42)IBA
10/2006
1Sorbitol (Yal)FDA Link
09/2005
1Glucagon-Like Peptide-1 ReceptorIBA
05/2005
1N-pyroglutamyl- glucagon-like peptide-1 (7-36)amideIBA
03/2004
1EnzymesIBA
12/2003
1SecretagoguesIBA
09/2003
1Proteins (Proteins, Gene)FDA Link
12/2002
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2002

Therapy/Procedure

3Therapeutics
01/2018 - 09/2002
2Injections
10/2016 - 10/2012
1Drug Therapy (Chemotherapy)
09/2005